Addressing Climate Change

There are more than 5 trillion pieces of plastic floating in our oceans. The U.S. transportation sector leads all other sectors in greenhouse gas emissions. Diseases that thrive in hot weather are killing important staple crops. Our reliance on products derived from fossil fuels is harming our planet.

Climate change is real but through biotechnology, we can meet these challenges head-on by making the same reliable plastics, foods, and fuels with less environmental impact.

Press Releases
January 9, 2023
The governments of Mexico, Canada and the United States should look to the framework in the U.S.-Mexico-Canada Agreement to continue growing the complementary trade and integrated markets throughout North America, agriculture-related associations said in a joint statement as the heads of the three…
December 12, 2022
VANCOUVER, BC, CANADA, and WASHINGTON, DC, UNITED STATES, Dec. 12, 2022 – Today, Novateur Ventures, a leading global life sciences advisory firm and Biotechnology Innovation Organization (BIO), the world's largest advocacy association for biosciences, research and academic institutions, launched an…
November 15, 2022
The next farm bill offers an opportunity to examine innovation’s influence on the resiliency of our economy in the face of global challenges, BIO wrote in a statement for the record to the Senate Agriculture Committee's Nov. 15 hearing on energy and rural development programs in the 2023 farm bill,…
Good Day BIO Newsletter
Subscribe to GoodDay BIO

Receive the best resource for the biotech industry with Good Day BIO, the only daily newsletter at the intersection of biotech, politics and policy. 

Letters, Comments & Testimony
January 23, 2023
BIO's response to the Office of Science & Technology Policy's Request for Information concerning the National Biotechnology & Biomanufacturing Initiative
January 3, 2023
On Tuesday, January 3rd, BIO submitted comments in response to the Food and Drug Administration’s (FDA) recent draft guidance containing recommendations for sponsors on monitoring growth and evaluating pubertal development in clinical trials which enroll pediatric participants. As planning,…
September 24, 2022
BIO and its members appreciate the opportunity to work with FDA to develop and align on approaches that are robust, practical, and expedite patient focused drug development. To further enhance the Guidance, we believe that a few areas would benefit from more explanation, examples, and references…